Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma

NCT00626704 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma
Sarcoma
Soft Tissue Sarcoma

Interventions

DRUG: AMG 655
OTHER: Placebo
DRUG: Doxorubicin

Sponsor

Amgen